Becton Dickinson (BDX) Reports In-Line Q4 EPS, Revenues Beat; Offers FY19 EPS Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. BROS
4. EXPE
5. ARM
6. QCOM
7. DDOG
8. CPAY
9. CHYM
10. W

Go back to Becton Dickinson (BDX) Reports In-Line Q4 EPS, Revenues Beat; Offers FY19 EPS Outlook Below Consensus

BD Announces Results For 2018 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2019 Guidance

November 6, 2018 6:00 AM EST

FRANKLIN LAKES, N.J., Nov. 6, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.402 billion for the fourth fiscal quarter ended September 30, 2018.  This represents an increase of 39.0 percent from the prior-year period, which is primarily due to the acquisition of C. R. Bard.  On a comparable, currency-neutral basis that includes the revenues of C. R. Bard in the current and prior year, fourth quarter revenues increased 8.4 percent over the prior-year period.  For the full fiscal year ended September 30, 2018, revenues of $15.983 billion... More